Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.

Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.

BACKGROUND:Zimbabwe is one of the thirty countries globally with a high burden of multidrug-resistant tuberculosis (TB) or rifampicin-resistant TB (MDR/RR-TB). Since 2010, patients diagnosed with MDR/RR-TB are being treated with 20-24 months of standardized second-line drugs (SLDs). The profile, man...

Full description

Bibliographic Details
Main Authors: Ronnie Matambo, Kudakwashe C Takarinda, Pruthu Thekkur, Charles Sandy, Sungano Mharakurwa, Talent Makoni, Ronald Ncube, Kelvin Charambira, Christopher Zishiri, Mkhokheli Ngwenya, Saziso Nyathi, Albert Chiteka, Elliot Chikaka, Shungu Mutero-Munyati
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0230848

Internet

https://doi.org/10.1371/journal.pone.0230848

Similar Items